Glycogen synthase kinase-3: a key kinase in retinal neuron apoptosis in early diabetic retinopathy

被引:13
|
作者
Li Zhaohui [1 ]
Ma Ling [2 ]
Chen Xiaodong [1 ]
Li Yonghao [1 ]
Li Shiyi [1 ]
Zhang Jinglin [1 ]
Lu Lin [1 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
关键词
retinal neuron; apoptosis; lithium chloride; glycogen synthase kinase-3; diabetic retinopathy; mitochondrial dysfunction; GANGLION-CELL LINE; SURVIVAL; DEATH; RATS; NEUROPROTECTION; GSK3-BETA; INSULIN; LITHIUM;
D O I
10.3760/cma.j.issn.0366-6999.20141347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diabetes-related pathogenic factors can cause retinal ganglion cell (RGC) apoptosis, but the specific mechanism is not very clear. The aim of this study is to investigate the correlation between glycogen synthase kinase-3 (GSK-3) activation and retinal neuron apoptosis. Methods In an in vitro experiment, the number of apoptotic RGC-5 cells differentiated by staurosporine was evaluated via flow cytometry and nuclei staining using Hoechst 33258. GSK-3 phosphorylation and caspase-3 activation in RGC-5 cells after serum deprivation were determined using Western blotting. Mitochondrial membrane potential was detected using the dye 5,5',6,6'-tetrachloro-1,1',3,3'-tetrethyl benzimidalyl carbocyanine iodide, and reactive oxygen species (ROS) levels were measured with dihydroethidium. In an in vivo experiment, the number of apoptotic retinal neurons was evaluated via terminal transferase dUTP nick-end labeling (TUNEL), and GSK-3 phosphorylation was determined using Western blotting, in the retinal nerve epithelial tissue of rats in which diabetes was induced by intravenous tail-vein injection of streptozotocin for 4 weeks. Results The levels of phosphorylated Ser21/9 in GSK-3 alpha/beta and p-T308/S473-AKT were lower and the cleaved caspase-3 levels were higher in the serum-deprived model (P <0.05). Lithium chloride treatment was associated with a slower rate of apoptosis, increased mitochondrial membrane potential, and decreased ROS levels in differentiated RGC-5 cells (P <0.05). The level of blood glucose and the number of TUNEL-positive cells in the whole-mounted retinas were higher (P <0.01), and the levels of phosphorylated Ser21/9 in GSK-3 alpha/beta and body weight were lower (P <0.05). However, the thickness of the retinal nerve epithelial layer was not significantly less in diabetic rats compared with control group. Lithium chloride intravitreal injection increased the levels of phosphorylated Ser21/9 in GSK-3 alpha/beta and decreased TUNEL-positive cells in the whole-mounted retinas. Conclusion GSK-3 kinase is closely related to retinal neuron apoptosis, and the application of the GSK-3 inhibitor lithium chloride can reduce retinal neuron apoptosis in early diabetic retinopathy.
引用
收藏
页码:3464 / 3470
页数:7
相关论文
共 50 条
  • [31] Regulation of glycogen synthase kinase-3 by hexosamines.
    Crook, ED
    Singh, L
    DIABETES, 1996, 45 : 348 - 348
  • [32] Glycogen Synthase Kinase-3 and Leukemia: Restoring the Balance
    Birch, Noah W.
    Zeleznik-Le, Nancy J.
    CANCER CELL, 2010, 17 (06) : 529 - 531
  • [33] Glycogen synthase kinase-3: A potential target for diabetes
    Teli, Divya M.
    Gajjar, Anuradha K.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 92
  • [34] Glycogen Synthase Kinase-3β in Ischemic Neuronal Death
    Hanumanthappa, Pradeep
    Densi, Asha
    Krishnamurthy, Rajanikant Golgodu
    CURRENT NEUROVASCULAR RESEARCH, 2014, 11 (03) : 271 - 278
  • [35] Presenilin 1 regulation of glycogen synthase kinase-3β
    Vestling, M
    Cowburn, RF
    Lovestone, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S517 - S517
  • [36] Targeting glycogen synthase kinase-3 in insulin signalling
    Frame, Sheelagh
    Zheleva, Daniella
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (03) : 429 - 444
  • [37] Hyperactivity: Glycogen synthase kinase-3 as a therapeutic target
    Mines, Marjelo A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 708 (1-3) : 56 - 59
  • [38] Targeting glycogen synthase kinase-3 in human melanoma
    Lo, R.
    Ribas, A.
    Witte, O. N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S211 - S211
  • [39] Primers on molecular pathways -: The glycogen synthase kinase-3β
    Billadeau, Daniel D.
    PANCREATOLOGY, 2007, 7 (5-6) : 398 - 402
  • [40] Glycogen synthase kinase-3: Properties, functions, and regulation
    Ali, A
    Hoeflich, KP
    Woodgett, JR
    CHEMICAL REVIEWS, 2001, 101 (08) : 2527 - 2540